Načítá se...
Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?
BACKGROUND: In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly prescribed to adults with congenital heart disease (CHD) and atrial arrhythmias without good evidence for either safety or efficacy. To address this gap, we initiated an ongoing prospective...
Uloženo v:
| Vydáno v: | Cardiovasc Drugs Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5591797/ https://ncbi.nlm.nih.gov/pubmed/28785894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-017-6745-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|